StartUp Health’s Q3 is an Even Crazier $9bn YTD October 11, 2017

StartUp Health’s Q3 is an Even Crazier $9bn YTD October 11, 2017

StartUp Health recently reported on Q3 digital health funding activity, joining a previous Rock Health study. According to StartUp, whose study takes a wider sample than Rock Health’s, funding in Q3 is already at $9bn, past last year’s $8bn. StartUp Health notes that it is very likely funding will surpass $10bn by the end of 2017.

Some key takeaways:

— Q3 charted $2.5bn in funding so far, which is less than Q2 ($3.8bn) but above Q3 funding in 2016 ($2.2bn).

— Series C and D deals provided 15% of all deals accomplished during this period, with Series D deals averaging $113 million.

— Deals are bigger than they ever have been at an average of $18 million apiece (versus $14 million in 2016).

— Half of all deals were in the personalized health and patient/consumer experience sectors—a difference from the B2B shifted noted in Rock Health’s study.

— The Bay Area leads deals in YTD, with NYC, Boston, and Chicago combined trailing.

Find out more about StartUp Health’s study and its comparison to the Rock Health study here.

Tags:
No Comments

Post a Comment